Press "Enter" to skip to content

Analysis of Bone Morphogenetic Protein Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to 2024

Bone

The “Bone Morphogenetic Protein Market” 2019 report provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries. Bone Morphogenetic Protein Market report also aims to provide useful and comprehensive insights into current market trends and future growth scenarios. Bone Morphogenetic Protein market report contains information like SWOT analysis, business highlights, strength, weakness, threats and opportunities of industry.

Top Manufacturers of Bone Morphogenetic Protein Market Are:

  • DePuy Synthes
  • Ember therapeutics Inc.
  • Integra Lifesciences Holdings Corporation
  • Medtronic PLC
  • R&D Systems
  • Sigma Aldrich Corporation
  • Smith & Nephew, Inc.
  • Stryker Corporation
  • Thermo Fischer Scientific
  • Zimmer Biomet Holdings, Inc.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245393

    Market Overview:

  • The global bone morphogenetic protein market was valued at USD 604.5 million in 2018 and is estimated to be valued at USD 620.21 million in 2024, witnessing a CAGR of 2.5%. The key factors that are responsible for the growth of the market include the growth in the incidences of sports-related injuries, the growing demand for minimally invasive surgeries, and technological advancements that are being done in the field of the bone morphogenetic protein.
  • According to the Centre for Disease Control and Prevention, the number of people participating in sports is increasing across both developing and developed nations, and this is ultimately leading to an increased number of sports injuries. Approximately, 8.6 million individuals are getting injured during sports annually, as stated by the National Institute of Health (NIH). This accounts for 34.1 people per 1,000. Spinal injury is the most frequent injury that was seen among the injured population during NIH survey.
  • As the number of such sports-related injury is increasing, there is a growing demand for bone morphogenetic protein, as this protein helps people who need to obtain bone formation.

    Scope of the Report:

  • Bone morphogenetic proteins (BMPs) are signaling molecules and most are a part of the Transforming Growth Factor-? (TGF?) family of proteins. BMPs have an important role in bone and cartilage formation, and embryogenesis. This report includes a detailed analysis of the types and applications of bone morphogenetic proteins.

    Bone Morphogenetic Protein Market Report Answers the Following Questions:

    • What will the market size and the growth rate be in 2024?
    • What are the key factors driving the global Bone Morphogenetic Protein market?
    • What are the key market trends impacting the growth of the global Bone Morphogenetic Protein market?
    • What are the challenges to market growth?
    • Who are the key vendors in the global Bone Morphogenetic Protein market?
    • What are the market opportunities and threats faced by the vendors in the global Bone Morphogenetic Protein market?
    • Trending factors influencing the market shares of the relevant regions.
    • What are the key outcomes of the five forces analysis of the global Bone Morphogenetic Protein market?

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245393

    Key Market Trends:

    Spinal Fusion is Expected to Hold the Highest Market Share in the Application Segment

    In the application segment, spinal fusion is believed to have the largest market size.

    Bone morphogenetic protein (BMP) is a protein which stimulates the formation of bone in the body and it is widely used in the spinal fusion surgery. Studies have revealed that BMP is accepted widely to facilitate the fusion at the rate greater than that of traditional bone graft surgery. Due to this reason, BMP gives the surgeon the freedom to perform the surgery with the ease of the improved fusion rate, which avoids the complications of an iliac crest autograft (hip) graft harvest. When the hip graft is avoided, it shortens the amount of the time taken for surgery, and reduces complication rates, allowing for a quicker and less painful recovery time.

    With the rise in the number of spinal surgeries and the ease of surgery with the help of BMP, its application is increasing rapidly in spinal fusion surgery.

    North America Dominates the Market and Expected to do Same in the Forecast Period

    North America currently dominates the market and is expected to continue its stronghold for a few more years. A well-established healthcare system and the adoption of novel technologies in the region are the prime factors responsible for the growth of the market in this region.

    The US FDA approved the protein molecule called rhBMP-2 in 2002, which later became the preferred procedure for the surgeries associated with bone in the United States. As per the data published by the National Institute of Health, approximately 1.62 million spinal fusion surgeries are performed annually in the United States, which indicates that there is a great scope for the BMP usage in the country.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    The report provides key statistics on the market status of the Bone Morphogenetic Protein Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Bone Morphogenetic Protein.

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14245393

    Report Objectives:

    • Analyzing the size of the Bone Morphogenetic Protein market on the basis of value and volume.
    • Accurately calculating the market segments, consumption, and other dynamic factors of different sections of the global Bone Morphogenetic Protein market.
    • Determining the key dynamics of the Bone Morphogenetic Protein market.
    • Highlighting significant trends of the Bone Morphogenetic Protein market in terms of manufacture, revenue, and sales.
    • Deeply summarizing top players of the Bone Morphogenetic Protein market and showing how they compete in the industry.
    • Studying industry processes and costs, product pricing, and various trends related to them.
    • Displaying the performance of different regions and countries in the global Bone Morphogenetic Protein market.

    Detailed TOC of Bone Morphogenetic Protein Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Growing Incidences of Sports-related Injury
    4.2.2 Rising Demand for Minimally Invasive Surgeries
    4.2.3 Technological Advancements
    4.3 Market Restraints
    4.3.1 High Cost of Procedure
    4.3.2 Alternative Treatment Availability
    4.4 Porter’s Five Force Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Type
    5.1.1 Recombinant Human Bone Morphogenetic Protein (rhBMP) – 2
    5.1.2 Recombinant Human Bone Morphogenetic Protein (rhBMP) -7
    5.2 Application
    5.2.1 Spinal Fusion
    5.2.2 Trauma
    5.2.3 Reconstructive Surgery
    5.2.4 Oral-maxillofacial
    5.3 Geography
    5.3.1 North America
    5.3.1.1 US
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 UK
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 DePuy Synthes
    6.1.2 Ember Therapeutics Inc.
    6.1.3 Integra Lifesciences Holdings Corporation
    6.1.4 Medtronic PLC
    6.1.5 R&D Systems
    6.1.6 Sigma Aldrich Corporation
    6.1.7 Smith & Nephew, Inc.
    6.1.8 Stryker Corporation
    6.1.9 Thermo Fischer Scientific
    6.1.10 Zimmer Biomet Holdings, Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    AquaFeed Market 2019 Industry Recent Developments, Size, Trends, Global Growth, Recent Developments and Latest Technology, Forecast Research Report 2024

    Glass Mold Market Share, Size 2019 Developing Rapidly with Recent Trends, Development, Revenue, Demand and Forecast to 2026 | Says Industryresearch.Biz

    Global Frequency Convertors Market: Regional Production & Consumption Volume, Size, Revenue and Growth Rate Forecast 2025

    Anticorrosive Paint Market 2019 Global Share, Size, Business Growth, Trend, Segmentation, Top Key Players Analysis Industry, Opportunities and Forecast to 2024